 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
6/28/23‡ Armistice Capital, LLC SC 13D/A 6/27/23 1:55K Avalo Therapeutics, Inc. Akin Gump Str… Office/FA
Steven Boyd³
2/9/23 Armistice Capital, LLC SC 13D/A 1:54K Avalo Therapeutics, Inc. Akin Gump Str… Office/FA
Steven Boyd³
8/11/22 Armistice Capital, LLC SC 13D/A 1:49K Avalo Therapeutics, Inc. Akin Gump Str… Office/FA
Steven Boyd³
3/15/22 Armistice Capital, LLC SC 13D/A 1:56K Avalo Therapeutics, Inc. Donnelley … Solutions/FA
Steven Boyd³
1/20/22‡ Armistice Capital, LLC SC 13D/A 1/19/22 1:73K Avalo Therapeutics, Inc. Akin Gump Str… Office/FA
Steven Boyd³
12/16/21 Armistice Capital, LLC SC 13D/A 1:41K Avalo Therapeutics, Inc. Donnelley … Solutions/FA
Steven Boyd³
11/8/21 Armistice Capital, LLC SC 13D/A 3:256K Avalo Therapeutics, Inc. Akin Gump Str… Office/FA
Steven Boyd³
10/15/21‡ Armistice Capital, LLC SC 13D/A 1:39K Avalo Therapeutics, Inc. Donnelley … Solutions/FA
Steven Boyd³
9/17/21 Armistice Capital, LLC SC 13D/A 1:104K Avalo Therapeutics, Inc. Akin Gump Straus… LLP/FA
Steven Boyd³
1/12/21 Armistice Capital, LLC SC 13D/A 1:103K Avalo Therapeutics, Inc. Seward & Kissel LLP
| ____________ | | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | | ¹ | Filing/Form Type: | | SC 13D | Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|
